Triangle headlines: TransEnterix job cuts; G1 raises $47M; UNC-NCSU biomed eningeering effort

In a wrapup of technology and life science news being reported by Triangle media outlets:

TransEnterix cuts jobs after FDA rejects robot
G1 Therapeutics adds to a big fundraiser
A look at the joint UNC-NCSU biomedical engineering effort

The details:

TransEnterix cuts jobs

TransEnterix cut one third of its work force following the recent FDA rejection of a robotic surgery system as it shifts emphasis to another system it hopes to win approval for next year, reports The News and Observer.

“The layoffs took place in Morrisville, where the company now employs 75 people, down from 136 last month. TransEnterix’s staff in Europe has grown from 20 to 30 as the company redoubles its efforts to sell its ALF-X robot in Europe and later in the Middle East and Asia,” the Raleigh newspaper says.

Read the details at:

http://www.newsobserver.com/news/business/article76942852.html#storylink=cpy

G1 Therapeutics raises $47 million

After raising $33 million last year and $12.5 million in 2014, Chapel Hill-based G1 Therapeutics has wrapped up a $47 million fundraiser.

“Investors include local venture capital groups like Hatteras Venture Partners and Eshelman Ventures. However, in the latest round, G1 disclosed that total investors have doubled from 10 to 20 groups and included new investors Aju IB Investment, Cowen Private Investments, Franklin Templeton Investments and Rock Springs Capital,” notes The Triangle Business Journal.